Freedom Meditech, Inc. Presents Data Showing Benefits of Non-Invasive Diabetes Screening and Glucose Monitoring in the Eye at London Conference

LONDON--(BUSINESS WIRE)--People with diabetes or who are at risk of developing the disease – now estimated at over 400 million globally - could reduce complications, improve quality of life and reduce healthcare costs by using new non-invasive technology to screen for and monitor the illness, according to a presentation by Freedom Meditech at the 6th Annual Diabetes and Diabetic Retinopathy Conference in London, England.